BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8432975)

  • 1. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
    Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
    J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human T lymphocytes by bryostatin.
    Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
    J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
    Galron D; Tamir A; Altman A; Isakov N
    Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
    Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
    Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
    Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
    Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.
    Sung SJ; Lin PS; Schmidt-Ullrich R; Hall CE; Walters JA; McCrady C; Grant S
    Int J Radiat Biol; 1994 Dec; 66(6):775-83. PubMed ID: 7814976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
    Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
    Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
    Galron D; Ansotegui IJ; Isakov N
    Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
    Esa AH; Boto WO; Adler WH; May WS; Hess AD
    Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    J Surg Res; 2009 May; 153(1):156-61. PubMed ID: 18486150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL; Bradshaw TD; Gescher A; Pettit GR
    Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.
    Szamel M; Bartels F; Resch K
    Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells.
    Tsutsumi A; Kubo M; Fujii H; Freire-Moar J; Turck CW; Ransom JT
    J Immunol; 1993 Mar; 150(5):1746-54. PubMed ID: 8436813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
    Lee HW; Smith L; Pettit GR; Smith JB
    Mol Pharmacol; 1997 Mar; 51(3):439-47. PubMed ID: 9058599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
    Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.